Home/Filings/4/0001387131-15-002580
4//SEC Filing

Adamis Pharmaceuticals Corp 4

Accession 0001387131-15-002580

CIK 0000887247operating

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:30 PM ET

Size

5.3 KB

Accession

0001387131-15-002580

Insider Transaction Report

Form 4
Period: 2015-08-13
Transactions
  • Purchase

    Common Stock

    2015-08-13$3.26/sh+9,800$31,93039,918 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.28, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000887247

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:30 PM ET
Size
5.3 KB